galantamine and Glaucoma, Suspect

galantamine has been researched along with Glaucoma, Suspect in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almasieh, M; Casanova, C; Di Polo, A; Kelly, ME; MacIntyre, JN; Pouliot, M; Vaucher, E1
Almasieh, M; Casanova, C; Di Polo, A; Kelly, ME; Zhou, Y1

Other Studies

2 other study(ies) available for galantamine and Glaucoma, Suspect

ArticleYear
Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma.
    Investigative ophthalmology & visual science, 2013, May-03, Volume: 54, Issue:5

    Topics: Acetylcholinesterase; Animals; Autoradiography; Cell Count; Cell Survival; Cholinesterase Inhibitors; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Galantamine; Injections, Intraperitoneal; Intraocular Pressure; Male; Ocular Hypertension; Rats; Rats, Inbred BN; Receptors, Muscarinic; Regional Blood Flow; Retinal Ganglion Cells; Retinal Vessels; Vasodilation

2013
Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors.
    Cell death & disease, 2010, Volume: 1

    Topics: Animals; Axons; Cell Death; Cell Survival; Cytoprotection; Galantamine; Glaucoma; Intraocular Pressure; Neurons; Neuroprotective Agents; Ocular Hypertension; Rats; Rats, Inbred BN; Receptors, Muscarinic; Retinal Ganglion Cells

2010